Community-led Action Research in Oncology: Pandemic-appropriate Radiotherapy Innovations Evaluated for LMICs
社区主导的肿瘤学行动研究:针对中低收入国家评估适合流行病的放射治疗创新
基本信息
- 批准号:10380931
- 负责人:
- 金额:$ 17.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2021-11-30
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAction ResearchAddressBackCOVID-19COVID-19 pandemicCancer CenterCancer ControlCaribbean regionCitiesClinicClinicalCommunitiesCommunity HealthcareComprehensive Cancer CenterConsensusCountryData CollectionDevelopmentDiseaseEnsureEvaluationFutureGoalsHealthHealthcareHondurasHygieneInfection preventionInternationalKnowledgeLatin AmericaLatin AmericanMaintenanceMalignant NeoplasmsManualsMedical OncologistMedical OncologyMedical SocietiesMentorsMethodsMorbidity - disease rateNew HampshireNorris Cotton Cancer CenterOncologyParticipantPatientsPhasePhysiciansPreparationProceduresProcessQuality of CareRadiation OncologyRadiation therapyReportingResearchResearch TechnicsResourcesRiskRouteSafetyScheduleScientistSeriesSourceTeleconferencesTestingUnited States National Institutes of HealthVirusbasecancer carecancer therapycare outcomescommunity based participatory researchcommunity centercostdesignevidence baseexperienceinfection riskinnovationinsightinterestlow and middle-income countriesmortalitymultidisciplinarymultimodalityoperationpandemic diseasepublic health emergencyresearch studyresponsesafety and feasibilitysafety testingventilation
项目摘要
ABSTRACT
Community-led Action Research in Oncology – Pandemic-appropriate Radiotherapy Innovations
Evaluated for LMICs (CLARO PARTE for LMICs)
This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA-
21-033. This participatory action research (PAR) study will assess radiotherapy (RT) innovations in partnership
with oncology professionals in Latin America and the Caribbean (LAC). We will leverage global experience and
relationships of the Community-led Action Research in Oncology (CLARO) global oncology research team at
Norris Cotton Cancer Center (NCCC) and involve RT professionals throughout LAC in evaluating “frugal
innovations,” which were developed during the COVID-19 pandemic and are defined as the creation of
unexpected solution that are simpler and disruptive alternatives to provide adequate healthcare within reach of
everyone (Tran et al. 2016). Our overall goal is to identify frugal innovations and evaluate them for safety,
efficiency, quality, feasibility, acceptability, and potential potency, to assess adaptability for use in future
pandemics, or other public health emergencies. Phase 1 involves convening LAC RT professionals in a Project
ECHOTM (Extension for Community Healthcare Outcomes) tele-mentoring partnership to share frugal
innovations devised by their clinics during the COVID-19 pandemic. The Latin-American and Caribbean
Society for Medical Oncology (SLACOM) will facilitate a panel of RT professionals joining the teleconferences.
In Phase 2, physicians and scientists experienced in radiation oncology and innovation will evaluate
innovations for effects on virus control, maintenance of clinical operations, and continuance of quality care by a
multidisciplinary team applying international standards. The innovations that meet standards will advance to
Phase 3, returning to the panel of LAC RT professionals where participants will engage in a Delphi consensus-
building process to assess feasibility, acceptability within their setting, and potential potency. Relying on highly
participatory and iterative processes, which are the hallmarks of Participatory Action Research (PAR), we will
move from data collection and reflection to action and improvement, leveraging relationships between NCCC’s
CLARO and SLACOM. Ultimately, we will develop a manual of scalable frugal RT innovations suitable for
LMICs in a pandemic. Innovations will be organized topically: routing, hygiene, ventilation, PPE, and
scheduling, etc. and further organized in matrixes by high/low impact and high/low cost.
抽象的
社区主导的肿瘤学行动研究 - 适合大流行的放射治疗创新
评估LMIC(LMIC的Claro Parte)
该申请是为了响应特殊利益通知(NOSI)而提交
21-033。这项参与行动研究(PAR)研究将评估放疗(RT)创新
拉丁美洲和加勒比海(LAC)的肿瘤专业人士。我们将利用全球经验,
社区主导的肿瘤学行动研究(CLARO)全球肿瘤研究团队的关系
诺里斯棉花癌中心(NCCC),并涉及整个LAC的RT专业人员评估“节俭
创新,“是在19009年大流行期间开发的,被定义为创造
意外的解决方案是更简单,更破坏性的替代方案,可提供足够的医疗保健
每个人(Tran等,2016)。我们的总体目标是确定节俭的创新并为了安全性进行评估,
效率,质量,可行性,可接受性和潜在效力,以评估将来使用的适应性
大流行病或其他公共卫生紧急情况。第1阶段涉及在项目中召集LAC RT专业人员
Echotm(社区医疗保健结果的扩展)远程合作伙伴关系以分享节俭
在COVID-19-19大流行期间,其诊所设计的创新。拉丁美洲和加勒比海
医学肿瘤学协会(Slacom)将促进由RT专业人员组成的专业人士。
在第二阶段,医生和科学家在放射肿瘤学和创新方面经历了评估
创新对病毒控制的影响,维持临床操作以及通过
多学科团队采用国际标准。符合标准的创新将提高到
第三阶段,返回LAC RT专业人员小组,参与者将参与Delphi共识 -
构建过程以评估可行性,可接受性和潜在效力。高度依赖
参与性和迭代过程,这是参与式行动研究(PAR)的标志,我们将
从数据收集和反思转变为行动和改进,利用NCCC之间的关系
克拉洛和斯拉科姆。最终,我们将制定一本可扩展的节俭RT创新手册
大流行中的LMIC。创新将局部组织:路由,卫生,通风,PPE和
日程安排等,并通过高/低冲击和高成本以矩阵进行进一步组织。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven D Leach其他文献
Steven D Leach的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven D Leach', 18)}}的其他基金
Developing ATAC-array as a novel epigenetic biomarker to guide personalized therapy in pancreatic cancer
开发 ATAC 阵列作为新型表观遗传生物标志物来指导胰腺癌的个性化治疗
- 批准号:
10512502 - 财政年份:2022
- 资助金额:
$ 17.18万 - 项目类别:
Administrative supplement for Early Drug Development Opportunity Program (EDDOP)
早期药物开发机会计划 (EDDOP) 的行政补充
- 批准号:
10677500 - 财政年份:2022
- 资助金额:
$ 17.18万 - 项目类别:
P30 Administrative Supplement to Cancer Center Support Grant to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network.
P30 癌症中心支持补助金的行政补充,旨在通过国家外展网络的社区健康教育者加强 NCI 支持的社区外展能力。
- 批准号:
10370916 - 财政年份:2021
- 资助金额:
$ 17.18万 - 项目类别:
Comprehensive genetic dissection of druggable KRAS targets
可药物 KRAS 靶点的全面基因剖析
- 批准号:
9476973 - 财政年份:2016
- 资助金额:
$ 17.18万 - 项目类别:
Comprehensive genetic dissection of druggable KRAS targets
可药物 KRAS 靶点的全面基因剖析
- 批准号:
9922888 - 财政年份:2016
- 资助金额:
$ 17.18万 - 项目类别:
Comprehensive genetic dissection of druggable KRAS targets
可药物 KRAS 靶点的全面基因剖析
- 批准号:
9080884 - 财政年份:2016
- 资助金额:
$ 17.18万 - 项目类别:
Functional Evaluation of Human Pancreatic Cancer Genes in a Zebrafish System
斑马鱼系统中人类胰腺癌基因的功能评估
- 批准号:
8464656 - 财政年份:2013
- 资助金额:
$ 17.18万 - 项目类别:
High resolution and single cell analyses of PanIN initiation and progression
PanIN 起始和进展的高分辨率单细胞分析
- 批准号:
8248212 - 财政年份:2011
- 资助金额:
$ 17.18万 - 项目类别:
High resolution and single cell analyses of PanIN initiation and progression
PanIN 起始和进展的高分辨率单细胞分析
- 批准号:
8095001 - 财政年份:2011
- 资助金额:
$ 17.18万 - 项目类别:
Confocal imaging resources for the JHU Zebrafish Center
JHU 斑马鱼中心的共焦成像资源
- 批准号:
7794133 - 财政年份:2010
- 资助金额:
$ 17.18万 - 项目类别:
相似国自然基金
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
- 批准号:82371028
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
亚热带高密度城市居民的步行动态热舒适需求的影响因素与量化体系研究
- 批准号:52308121
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
YTHDF1通过m6A修饰调控耳蜗毛细胞炎症反应在老年性聋中的作用机制研究
- 批准号:82371140
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
成骨谱系功能异常在X-连锁显性低血磷性佝偻病/骨软化症发病中的作用与机制研究
- 批准号:82370888
- 批准年份:2023
- 资助金额:65.00 万元
- 项目类别:面上项目
小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
- 批准号:82371248
- 批准年份:2023
- 资助金额:47.00 万元
- 项目类别:面上项目
相似海外基金
Vagal airway sensory nerve activation by beta-coronavirus spike protein
β-冠状病毒刺突蛋白激活迷走神经气道感觉神经
- 批准号:
10748485 - 财政年份:2023
- 资助金额:
$ 17.18万 - 项目类别:
RAPIDLY EMERGING ANTIVIRAL DRUG DEVELOPMENT INITIATIVE- AViDD CENTER (READDI-AC)
迅速崛起的抗病毒药物开发计划 - AViDD 中心 (READDI-AC)
- 批准号:
10513679 - 财政年份:2022
- 资助金额:
$ 17.18万 - 项目类别: